Skip to main content
. 2021 Apr 15;12:645264. doi: 10.3389/fphar.2021.645264

FIGURE 4.

FIGURE 4

Rifapentine kill curve and resistance emergence in the HFS-MAC. (A-C). There was no difference in the total as well as drug resistant subpopulation among the three rifapentine exposures tested in the HFS-MAC. The rifapentine monotherapy failed after 4 days of treatment. (D). Inhibitory Sigmoid Emax model showed highest r 2 = 0.993 and lowest Akaike Information Criteria score (Akaike, 1974) = 0.080 on study day 4, where EC50 was calculated as AUC/MIC of 1.025.